tirzepatide pregnancy use Tirzepatide, Mounjaro, Period Changes and What are the recommendations for

Some individuals find that alternating between two dose levels provides effective maintenance at lower average doses than continuous higher dosing

In Phase 3 studies conducted under controlled conditions, tirz epatide demonstratedsubstantial and sustained reductions in body weight, with participants achieving average weight reductions of up to approximately 2223% over 72 weeks, depending on dose and study protocol

The SURPASS-2 trial (PubMed ID 34170647) reported greater HbA1c reductions with tirzepatide versus semaglutide 1 mg in type 2 diabetes cohorts, while SURMOUNT-1 (PubMed ID 35658024) documented substantial body-weight reductions versus placebo in obesity cohorts

Your care is reviewed by Dr

This is not rigid